| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.01 |